UNSPSC 51112601: Carmustine

This classification denotes a nitrosourea compound and dna adduct forming agent with the molecular formula C5H9Cl2N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U68WG3173Y, chemically known as 1,3-bis(beta-chloroethyl)-1-nitrosourea but more generally known as carmustine, which bears US NIH Compound Identifier 2578. European Medicines Agency schedules Carmustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06132MIG.

UNSPSC 51112601 Carmustine, a Commodity code, covers pharmaceutical products—specifically the chemotherapy agent carmustine—procured by state and local health agencies. The single recent opportunity in the record, Texas Health and Human Services Commission RFI No. HHS0017013 (posted April 3, 2026), does not solicit carmustine directly; instead, it seeks vendor information on implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program that would establish direct contracting relationships between the state pharmacy benefit program and manufacturers to improve prescription fulfillment and cost management. The RFI explores vendor capacity to enter direct contracts outside traditional pharmacy benefit manager, group purchasing organization, and wholesaler channels, including negotiated net pricing models and value-based agreements. While the RFI's scope encompasses pharmaceutical procurement broadly, it does not isolate carmustine or other specific chemotherapy agents as line items.

The issuing body is the Texas Health and Human Services Commission, a state health agency. Geographic activity is limited to Texas based on the single recent opportunity. The RFI functions as a market-intelligence tool rather than a formal competitive solicitation and does not include award values, budget ranges, set-aside designations, or response deadlines binding future procurement. The state intends to use vendor responses to inform subsequent formal solicitations with established specifications and pricing models. No recent opportunities specifically soliciting carmustine as a named product appear in the source, limiting visibility into current state and local demand for this commodity code.